Actively Recruiting
Special Drug Use-results Survey for Long-term Use (Fostamatinib)
Led by Kissei Pharmaceutical Co., Ltd. · Updated on 2025-01-03
149
Participants Needed
1
Research Sites
278 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.
CONDITIONS
Official Title
Special Drug Use-results Survey for Long-term Use (Fostamatinib)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with chronic idiopathic thrombocytopenic purpura who are treatment with fostamatinib for the first time.
You will not qualify if you...
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Research site
Tokyo and Japanese Other Cities, Japan
Actively Recruiting
Research Team
K
Kazunori Abe, director
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here